Safety concerns for two big anemia drugs.
D000740:Anemia / Q000188:drug therapy*; D000068256:Darbepoetin alfa; D004348:Drug Labeling; D064420:Drug-Related Side Effects and Adverse Reactions; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa